Sign In
Buy AUPH
$16.37
+0.700 (+4.47%)
At Close: Jun 04, 2026
Biotechs Feel The Bern
02:30pm, Monday, 03'rd Feb 2020
Healthcare is entering a period where election cycle impact will grow. The Medicare for All healthcare plan will begin to get factored based on the success of t
The Cutting Edge Of Systematic Investing
05:48pm, Tuesday, 21'st Jan 2020
Systematic or Quantitative Investing continues to be a bigger part of the market as it delivers stronger market-beating returns fairly consistently. Experts oft
Morgan Stanley sees 15% upside in McKesson in premarket analyst action
12:32pm, Friday, 10'th Jan 2020
Aerie Pharmaceuticals (NASDAQ:AERI) initiated with Neutral rating and $27 (6% upside) price target at Bank of America.Aurinia Pharmaceuticals (AUP CN) initiated with Buy rating and C$35.26 (32% upside
Biotech Bonanza: 2020 Outlook In An Election Year
09:15pm, Wednesday, 08'th Jan 2020
Biotechs closed out 2019 on a strong note, with the fourth quarter providing the longest sustained rally of the entire year. Favorable regulatory shifting, a ti
Hearing Dealreporter Suggests Aurinia Pharmaceuticals Takeover Is Being Eyed By Other Larger Pharma Competitors; Unconfirmed
12:00am, Thursday, 02'nd Jan 2020Aurinia Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.
12:00am, Thursday, 26'th Dec 2019The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict
12:00am, Tuesday, 24'th Dec 2019The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data
12:23pm, Wednesday, 18'th Dec 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 17) Acceleron Pharma Inc (NASDAQ: XLRN ) Allergan plc
Aurinia Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.
12:00am, Tuesday, 17'th Dec 2019H.C. Wainwright Maintains Buy on Aurinia Pharmaceuticals, Raises Price Target to $32
12:00am, Monday, 16'th Dec 2019
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Dec. 12.) Allergan plc (NYSE: AGN ) Amgen, Inc.
